A comprehensive review of anticancer mechanisms of action of Alantolactone
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive review of anticancer mechanisms of action of Alantolactone
Authors
Keywords
Sesquiterpene lactone, Alantolactone, Anticancer, Apoptosis, Metastasis, Cell cycle
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 136, Issue -, Pages 111231
Publisher
Elsevier BV
Online
2021-01-15
DOI
10.1016/j.biopha.2021.111231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia
- (2020) Ce Shi et al. Cancer Cell International
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model
- (2019) Changtian Yin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway
- (2019) Wei He et al. FREE RADICAL RESEARCH
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
- (2019) Xing Kang et al. Artificial Cells Nanomedicine and Biotechnology
- Antitumor activity of alantolactone in lung cancer cell lines NCI‐H1299 and Anip973
- (2019) Jianli Liu et al. JOURNAL OF FOOD BIOCHEMISTRY
- Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells
- (2019) Xiaoguang Xu et al. LIFE SCIENCES
- The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment
- (2019) Yubo Zhang et al. PHYTOCHEMISTRY REVIEWS
- Natural Product Target Network Reveals Potential for Cancer Combination Therapies
- (2019) Steven R. Chamberlin et al. Frontiers in Pharmacology
- Marine Natural Products: A Source of Novel Anticancer Drugs
- (2019) Shaden A. M. Khalifa et al. Marine Drugs
- ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
- (2019) Anastasiya V. Snezhkina et al. Oxidative Medicine and Cellular Longevity
- Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan
- (2019) Hannah Otterbein et al. Cancers
- Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms
- (2018) Raimundo Gonçalves de Oliveira Júnior et al. FITOTERAPIA
- The role of TGF-β/SMAD4 signaling in cancer
- (2018) Ming Zhao et al. International Journal of Biological Sciences
- Special Issue: Natural Products: Anticancer and Beyond
- (2018) Qingbin Cui et al. MOLECULES
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway
- (2018) Xiaohe Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB
- (2018) Ruizhi He et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
- (2018) Hailun Zheng et al. MOLECULAR CARCINOGENESIS
- Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
- (2018) Asghar Fallah et al. BIOMEDICINE & PHARMACOTHERAPY
- Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades
- (2017) Xun Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Understanding the molecular mechanisms driving metastasis
- (2017) Joan Massagué et al. Molecular Oncology
- Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling
- (2017) Ya-Rong Liu et al. PHYTOTHERAPY RESEARCH
- The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis
- (2017) Federica Fusella et al. Nature Communications
- Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog
- (2017) Kamdje Armel Herve Nwabo et al. Cancer Biology & Medicine
- TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells
- (2017) Katie L. Bailey et al. PLoS One
- Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative
- (2017) Wendy Soria Sotillo et al. PLoS One
- Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity
- (2017) Anwar Rayan et al. PLoS One
- Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
- (2017) Amara Maryam et al. Scientific Reports
- Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells
- (2016) Junmin Zhang et al. BIOCHEMICAL PHARMACOLOGY
- New Synthesis of Eremophilanes from Alantolactone
- (2016) A. V. Semakov et al. CHEMISTRY OF NATURAL COMPOUNDS
- Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones
- (2016) Yulin Ren et al. CURRENT MEDICINAL CHEMISTRY
- Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
- (2016) Yahui Ding et al. Journal of Hematology & Oncology
- Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway
- (2016) YAN JIANG et al. Oncology Letters
- Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance
- (2015) Yao Yao et al. APOPTOSIS
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
- (2015) Jaemoo Chun et al. CANCER LETTERS
- Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer SK-MES-1 Cells
- (2015) Peng Zhao et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
- (2015) Gordon M. Cragg et al. MEDICAL PRINCIPLES AND PRACTICE
- Anti-allergic effects of sesquiterpene lactones from the root of Aucklandia lappa Decne
- (2015) CHANG-SEOB SEO et al. Molecular Medicine Reports
- Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells
- (2015) DONGLEI LIU et al. Oncology Letters
- Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers
- (2015) Chenjie Zeng et al. JAMA Oncology
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion
- (2013) Wei Wei et al. APOPTOSIS
- Cancer therapeutics: Targeting the apoptotic pathway
- (2013) Khurum H. Khan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression
- (2013) Chunhui Yang et al. IUBMB LIFE
- Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway
- (2013) YU ZHANG et al. Molecular Medicine Reports
- Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
- (2013) Azhar Rasul et al. TheScientificWorldJOURNAL
- Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression
- (2013) Xu-Guang Mi et al. TOXICOLOGY LETTERS
- Role of STAT3 in Cancer Metastasis and Translational Advances
- (2013) Mohammad Zahid Kamran et al. Biomed Research International
- Role of the Crosstalk between Autophagy and Apoptosis in Cancer
- (2013) Minfei Su et al. Journal of Oncology
- Sesquiterpene lactones isolated from indigenous Middle Eastern plants inhibit tumor promoter-induced transformation of JB6 cells
- (2012) Melody Saikali et al. BMC Complementary and Alternative Medicine
- Alantolactone induces activation of apoptosis in human hepatoma cells
- (2012) Jia-Chuan Lei et al. FOOD AND CHEMICAL TOXICOLOGY
- Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells
- (2012) Jaemoo Chun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction
- (2012) Muhammad Khan et al. IUBMB LIFE
- Alantolactone Induces Apoptosis in HepG2 Cells through GSH Depletion, Inhibition of STAT3 Activation, and Mitochondrial Dysfunction
- (2012) Muhammad Khan et al. Biomed Research International
- Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
- (2011) Irmgard Merfort CURRENT DRUG TARGETS
- The cell cycle and cancer
- (2011) Gareth H Williams et al. JOURNAL OF PATHOLOGY
- Autophagy and apoptosis: what is the connection?
- (2011) Jacob M. Gump et al. TRENDS IN CELL BIOLOGY
- Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma
- (2010) Ming Yan et al. BMC CANCER
- What made sesquiterpene lactones reach cancer clinical trials?
- (2010) Akram Ghantous et al. DRUG DISCOVERY TODAY
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Ultrasound-assisted extraction of alantolactone and isoalantolactone from Inula helenium roots
- (2010) Antoaneta Trendafilova et al. Pharmacognosy Magazine
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Nrf2-mediated induction of detoxifying enzymes by alantolactone present inInula helenium
- (2008) Ji Yeon Seo et al. PHYTOTHERAPY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search